L E M Elstgeest1, I A Brouwer1, B Wj H Penninx2, N M van Schoor3, M Visser1,4. 1. Department of Health Sciences and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. 2. Department of Psychiatry and the EMGO Institute for Health and Care Research, VU University Medical Center/GGZ inGeest, Amsterdam, The Netherlands. 3. Department of Epidemiology and Biostatistic and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands. 4. Department of Internal Medicine, Nutrition and Dietetics, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND/ OBJECTIVES: The roles of vitamin B12 and homocysteine concentration in depression are not clear. We investigated cross-sectional and prospective associations of serum vitamin B12 and plasma homocysteine with depressive symptoms in Dutch older adults. SUBJECTS/ METHODS: In the Longitudinal Aging Study Amsterdam (LASA), blood was collected in 1995/1996 among 1352 men and women aged ⩾65 years. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) six times from 1995/1996 to 2011/2012. Multiple linear regression and mixed models were used to assess whether vitamin B12 and homocysteine were associated with severity at baseline and course of depressive symptoms over 16 years. Cox regression analyses were performed for the associations with incidence of depression (CES-D ⩾16 and/or antidepressant use). All analyses were adjusted for sociodemographic characteristics and lifestyle factors. RESULTS: Vitamin B12 was neither cross-sectionally (n=1205) nor prospectively (n=1012) associated with depressive symptoms (adjusted β for CES-D over time, lowest versus highest quartile: -0.04 (95% confidence interval (CI): -0.15-0.06)). We also found no association with incident depression (n=853), except for a higher risk of depression over time in younger participants (aged 64.8-73.4 years; continuous vitamin B12, adjusted hazard ratio per s.d.: 1.38 (95% CI: 1.10-1.72)). For homocysteine, no associations were found, except for a lower risk of depression in younger participants. CONCLUSIONS: Our study did not confirm earlier shown associations of serum vitamin B12 and plasma homocysteine with severity and course of depressive symptoms and incidence of depression in older adults. Further research into the influence of homocysteine metabolism on mental health is needed.
BACKGROUND/ OBJECTIVES: The roles of vitamin B12 and homocysteine concentration in depression are not clear. We investigated cross-sectional and prospective associations of serum vitamin B12 and plasma homocysteine with depressive symptoms in Dutch older adults. SUBJECTS/ METHODS: In the Longitudinal Aging Study Amsterdam (LASA), blood was collected in 1995/1996 among 1352 men and women aged ⩾65 years. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) six times from 1995/1996 to 2011/2012. Multiple linear regression and mixed models were used to assess whether vitamin B12 and homocysteine were associated with severity at baseline and course of depressive symptoms over 16 years. Cox regression analyses were performed for the associations with incidence of depression (CES-D ⩾16 and/or antidepressant use). All analyses were adjusted for sociodemographic characteristics and lifestyle factors. RESULTS:Vitamin B12 was neither cross-sectionally (n=1205) nor prospectively (n=1012) associated with depressive symptoms (adjusted β for CES-D over time, lowest versus highest quartile: -0.04 (95% confidence interval (CI): -0.15-0.06)). We also found no association with incident depression (n=853), except for a higher risk of depression over time in younger participants (aged 64.8-73.4 years; continuous vitamin B12, adjusted hazard ratio per s.d.: 1.38 (95% CI: 1.10-1.72)). For homocysteine, no associations were found, except for a lower risk of depression in younger participants. CONCLUSIONS: Our study did not confirm earlier shown associations of serum vitamin B12 and plasma homocysteine with severity and course of depressive symptoms and incidence of depression in older adults. Further research into the influence of homocysteine metabolism on mental health is needed.
Authors: Osvaldo P Almeida; Andrew H Ford; Varsha Hirani; Vash Singh; Frank M vanBockxmeer; Kieran McCaul; Leon Flicker Journal: Br J Psychiatry Date: 2014-09-25 Impact factor: 9.319
Authors: Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Lisette C P G M de Groot; Paul Lips; Johannes H Smit; Wija A van Staveren Journal: J Bone Miner Res Date: 2005-02-07 Impact factor: 6.741
Authors: Andrew H Ford; Leon Flicker; Jenny Thomas; Paul Norman; Konrad Jamrozik; Osvaldo P Almeida Journal: J Clin Psychiatry Date: 2008-08 Impact factor: 4.384
Authors: Fernando Castro; Jesús Melgarejo; Carlos A Chavez; Gabriel A de Erausquin; Joseph D Terwilliger; Joseph H Lee; Gladys E Maestre Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: J Douglas Bremner; Kasra Moazzami; Matthew T Wittbrodt; Jonathon A Nye; Bruno B Lima; Charles F Gillespie; Mark H Rapaport; Bradley D Pearce; Amit J Shah; Viola Vaccarino Journal: Nutrients Date: 2020-08-13 Impact factor: 5.717
Authors: Mônica Araujo Batalha; Paula Normando Dos Reis Costa; Ana Lorena Lima Ferreira; Nathalia C Freitas-Costa; Amanda C Cunha Figueiredo; Setareh Shahab-Ferdows; Daniela Hampel; Lindsay H Allen; Rafael Pérez-Escamilla; Gilberto Kac Journal: Front Nutr Date: 2022-07-11